Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Craigbadon Dec 19, 2016 9:31am
134 Views
Post# 25618501

RE:RE:RE:RE:RE:News!!!

RE:RE:RE:RE:RE:News!!!Still a great deal for investment banks and institutional holders so long as retail keeps buying into it. Even forcing the $1 warrants allows the placement buyers to make a juicy profit even at these lows, the investment banks make juicy commissions, share count gets bloated and the cycle repeats as sales estimates get bigger and have not been delivered upon to this day.

EddySantana wrote: Fear in the collective consciousness of the institutional shareholder base that the claims may have merit


Bullboard Posts